Aardvark Therapeutics

AARDNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$125.838 M

$5.75 +3.23%

Close of 22 Sept 2026

Revenue

—

Not reported

Earnings

-$57.6M

Loss-making

Shares outstanding

21,884,846

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#291TuHURA BiosciencesHURA$135.7M
#292Inovio PharmaceuticalsINO$133.4M
#293Aardvark TherapeuticsAARD$125.8M
#294OnKure TherapeuticsOKUR$125.5M
#295Coya TherapeuticsCOYA$124.3M

What if Aardvark Therapeutics were worth as much as…

Open the what-if tool →

Gold $30.2T

$1,381,503

Per share 240,261× higher

Bitcoin $1.74T

$79,582.70

Per share 13,840× higher

Nvidia $5.52T

$252,035.91

Per share 43,832× higher

Or at a round number

$200.0M $500.0M $1.00B $2.00B

Where these numbers come from

Share counts and financials for Aardvark Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.